Hasil Pencarian - Irma Convertino

  • Menampilkan 1 - 8 hasil dari 8
Perbaiki Hasil
  1. 1
    Drug Safety and Relevant Issues in the Real-World

    Drug Safety and Relevant Issues in the Real-World oleh Maria Antonietta Barbieri, Natasha Irrera, Irma Convertino

    Diterbitkan 2023-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Is There a Risk of Lymphoma Associated With Anti-tumor Necrosis Factor Drugs in Patients With Inflammatory Bowel Disease? A Systematic Review of Observational Studies

    Is There a Risk of Lymphoma Associated With Anti-tumor Necrosis Factor Drugs in Patients With Inflammatory Bowel Disease? A Systematic Review of Observational Studies oleh Sara Ferraro, Luca Leonardi, Irma Convertino, Corrado Blandizzi, Corrado Blandizzi, Marco Tuccori, Marco Tuccori

    Diterbitkan 2019-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patients

    Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patients oleh Irma Convertino, Marco Tuccori, Sara Ferraro, Giulia Valdiserra, Emiliano Cappello, Daniele Focosi, Corrado Blandizzi

    Diterbitkan 2020-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline

    Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline oleh Marco Tuccori, Sara Ferraro, Irma Convertino, Emiliano Cappello, Giulia Valdiserra, Corrado Blandizzi, Fabrizio Maggi, Daniele Focosi

    Diterbitkan 2020-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis

    Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis oleh Irma Convertino, Valentina Lorenzoni, Rosa Gini, Giuseppe Turchetti, Elisabetta Fini, Sabrina Giometto, Claudia Bartolini, Olga Paoletti, Sara Ferraro, Emiliano Cappello, Giulia Valdiserra, Marco Bonaso, Corrado Blandizzi, Marco Tuccori, Ersilia Lucenteforte

    Diterbitkan 2023-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Validation of algorithms for selecting rheumatoid arthritis patients in the Tuscan healthcare administrative databases

    Validation of algorithms for selecting rheumatoid arthritis patients in the Tuscan healthcare administrative databases oleh Irma Convertino, Massimiliano Cazzato, Sabrina Giometto, Rosa Gini, Giulia Valdiserra, Emiliano Cappello, Sara Ferraro, Silvia Tillati, Claudia Bartolini, Olga Paoletti, Valentina Lorenzoni, Leopoldo Trieste, Matteo Filippi, Giuseppe Turchetti, Michele Cristofano, Corrado Blandizzi, Marta Mosca, Ersilia Lucenteforte, Marco Tuccori

    Diterbitkan 2021-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy

    Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy oleh Irma Convertino, Massimiliano Cazzato, Silvia Tillati, Sabrina Giometto, Rosa Gini, Giulia Valdiserra, Emiliano Cappello, Sara Ferraro, Marco Bonaso, Claudia Bartolini, Olga Paoletti, Valentina Lorenzoni, Leopoldo Trieste, Matteo Filippi, Giuseppe Turchetti, Michele Cristofano, Corrado Blandizzi, Corrado Blandizzi, Marta Mosca, Ersilia Lucenteforte, Marco Tuccori, Marco Tuccori

    Diterbitkan 2023-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Italian Emergency Department Visits and Hospitalizations for Outpatients’ Adverse Drug Events: 12-Year Active Pharmacovigilance Surveillance (The MEREAFaPS Study)

    Italian Emergency Department Visits and Hospitalizations for Outpatients’ Adverse Drug Events: 12-Year Active Pharmacovigilance Surveillance (The MEREAFaPS Study) oleh Niccolò Lombardi, Giada Crescioli, Alessandra Bettiol, Marco Tuccori, Marco Tuccori, Annalisa Capuano, Roberto Bonaiuti, Alessandro Mugelli, Mauro Venegoni, Giuseppe Danilo Vighi, Alfredo Vannacci, Alfredo Vannacci, the MEREAFaPS Study group, Maria Luisa Aiezza, Alessandra Bettiol, Daria Bettoni, Corrado Blandizzi, Roberto Bonaiuti, Valentina Borsi, Annalisa Capuano, Errica Cecchi, Irma Convertino, Giada Crescioli, Martina Del Lungo, Cristina Di Mauro, Gabriella Farina, Sara Ferraro, Annamaria Fucile, Elena Galfrascoli, Elisabetta Geninatti, Linda Giovannetti, Luca Leonardi, Rosa Liccardo, Niccolò Lombardi, Anna Marra, Eleonora Marrazzo, Giovanna Monina, Alessandro Mugelli, Silvia Pagani, Maria Parrilli, Concetta Rafaniello, Francesco Rossi, Marco Rossi, Stefania Rostan, Marco Ruocco, Marita Sironi, Giulia Spada, Liberata Sportiello, Marco Tuccori, Alfredo Vannacci, Mauro Venegoni, Giuditta Violetta Vighi, Giuseppe Danilo Vighi

    Diterbitkan 2020-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: